114643-57-1

Upstream product

• 108-24-7 acetic anhydride 
• 103930-45-6 methyl 4-O-benzyl-2,6-dideoxy-2-fluoro-α-L-idopyranoside 
• 34388-70-0 methyl 2-O-acetyl-3,4-O-isopropylidene-α-L-fucofuranoside 
• 34388-71-1 methyl 2-O-acetyl-α-L-fucofuranoside 
• 103930-44-5 methyl 2,3-anhydro-4-O-benzyl-6-deoxy-α-L-gulopyranoside 
• 103930-43-4 methyl 2-O-acetyl-4-O-benzyl-3-O-p-tolylsulfonyl-α-L-fucofuranoside 
• 103930-42-3 methyl 2-O-acetyl-3-O-p-tolylsulfonyl-α-L-fucofuranoside 

Downstream Products

• 211993-35-0 4-Nitro-benzoic acid (2S,3R,4R,5S,6R)-6-((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-5-fluoro-4-iodo-2-methyl-tetrahydro-pyran-3-yl ester 
• 211993-26-9 1-O-acetyl-2,3,6-trideoxy-2-fluoro-3-iodo-4-O-p-nitrobenzoyl-α-L-talopyranose 
• 211993-25-8 methyl 2,3,6-trideoxy-2-fluoro-3-iodo-4-O-p-nitrobenzoyl-α-L-talopyranoside 
• 211993-27-0 2,3,6-trideoxy-2-fluoro-3-iodo-4-O-p-nitrobenzoyl-α-L-talopyranosyl bromide 

Relevant academic research and scientific papers

SYNTHESIS OF ANTITUMOR-ACTIVE 7-O-(2,6-DIDEOXY-2-FLUORO-α-L-TALOPYRANOSYL)-DAUNOMYCINONE AND -ADRIAMYCINONE

The title compounds (17 and 23) were prepared by coupling 3,4-di-O-acetyl-2,6-dideoxy-2-fluoro-α-L-talopyranosyl bromide (15) with daunomycinone.The key step in the preparation of 15 was the epoxide-ring opening of methyl 2,3-anhydro-4-O-benzyl-6-deoxy-α-